Detection of Chlorhexidine in Tracheal Secretions After Routine Oral Care With Chlorhexidine Gluconate

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

November 4, 2015

Primary Completion Date

January 5, 2017

Study Completion Date

January 9, 2017

Conditions
ChlorhexidineIntensive Care
Interventions
DEVICE

Endotracheal tubes not allowing SSD

In the participating center, a bundle of Ventilator-Associated Pneumonia (VAP) prevention will be applied: elevate the head of the bed to 30°-45°, regular oral care, manage patients with sedation algorithm, assess readiness to extubate daily, intermittent control of endotracheal tube cuff pressure

DEVICE

Endotracheal tubes allowing SSD

"In the participating center, a bundle of VAP prevention will be applied: elevate the head of the bed to 30°-45°, regular oral care, manage patients with sedation algorithm, assess readiness to extubate daily, intermittent control of endotracheal tube cuff pressure.~In addition, SSD will be realized using a 10 ml syringe at in attending frequency of 2 hours."

Trial Locations (1)

85170

CHD Vendee, La Roche-sur-Yon

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

collaborator

University Hospital, Angers

OTHER_GOV

lead

Centre Hospitalier Departemental Vendee

OTHER

NCT02583321 - Detection of Chlorhexidine in Tracheal Secretions After Routine Oral Care With Chlorhexidine Gluconate | Biotech Hunter | Biotech Hunter